_______________________________________________________________________________________________________ πŸ“… October 22, 2026 | πŸ•’ 11 PM Eastern Time US | πŸ•’ 3 PM GMT | ⏳ 60 Minutes


$240 

Registration Options (LIVE ONLY): *
COMBO: Add 30-Day Complimentary Recording Access: *

Learn More


A practical approach to evaluating proposed GMP changes before implementation, including change classification, product and process risk, validation and testing requirements, regulatory impact, implementation controls, and the evidence needed to justify the change.


A proposed change can affect more than the equipment, process, specification, facility, or document being modified. Before approval, the organization must understand how far the change reaches, what it could affect, whether the validated state remains supported, and what testing, qualification, validation, documentation, or regulatory action may be required before the change can be implemented.


This session examines how to make those assessments systematically. It covers classifying the change, evaluating product and process risk, determining validation and testing needs, assessing potential regulatory impact, and planning implementation. The discussion also addresses post-implementation monitoring and effectiveness checks so that the organization can confirm the change achieved its intended result without introducing unexpected quality or process issues.


| WHY YOU SHOULD ATTEND

The Impact Has to Be Understood Before Approval

A seemingly limited change can affect process performance, product quality, validation status, documentation, or regulatory commitments. The strength of the change control depends on identifying those consequences early enough to determine the appropriate testing, validation, risk controls, approvals, and implementation requirements.


Follow the Change From Assessment Through Verification

The session begins with defining and classifying the proposed change, then moves through impact and risk assessment, validation and testing decisions, regulatory considerations, documentation, and implementation planning. It concludes with post-implementation monitoring and effectiveness checks to confirm that intended results were achieved without creating new problems.

| AREAS COVERED

  • Classifying GMP changes by type, significance, scope, and potential process impact
  • Assessing effects on product quality, process performance, facilities, equipment, specifications, and the validated state
  • Determining appropriate testing, qualification, validation, or revalidation before implementation
  • Applying quality risk assessment to change evaluation and implementation planning
  • Evaluating regulatory impact, documentation requirements, approvals, and implementation controls
  • Post-implementation monitoring and effectiveness checks for intended and unintended effects

| WHO SHOULD ATTEND

  • Quality Assurance
  • Quality Systems
  • Validation
  • Manufacturing and Production
  • Engineering
  • Facilities
  • Quality Control
  • Regulatory Affairs
  • Technical Operations
  • Process Owners and Change Control Owners
  • Quality and Manufacturing Management



Course Director: Danielle DeLucy

Danielle DeLucy, is the owner of ASA Training and Consulting, LLC, providing pharmaceutical and biologics companies with quality systems and regulatory compliance support. Her industry experience includes Quality Control microbiology, sterility assurance, product quality, and QA oversight of filling and packaging operations. She has supported regulatory inspections, inspection preparation, and organizations responding to warning letters and consent decrees while strengthening quality systems and compliance practices.